Apex Biotechnology Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,945	1,852	1,677	2,244	2,132
Revenue Growth (YoY)	5.00%	10.48%	-25.29%	5.28%	6.30%
Cost of Revenue	1,406	1,331	1,145	1,667	1,560
Gross Profit	538.74	521.34	531.12	576.84	571.51
Selling, General & Admin	234.33	231.31	224.26	234.83	216.77
Research & Development	149.37	161.52	163.33	165.45	153.29
Operating Expenses	398.02	392.88	389.4	400.28	366.56
Operating Income	140.73	128.46	141.72	176.56	204.95
Interest Expense	-3.39	-3.64	-4.39	-5.4	-12.53
Interest & Investment Income	2.99	4.34	3.2	1.15	2.01
Currency Exchange Gain (Loss)	-	17.6	18.97	54.71	-58.6
Other Non Operating Income (Expenses)	49.57	2.13	3.2	0.32	17.41
EBT Excluding Unusual Items	189.9	148.9	162.7	227.35	153.23
Gain (Loss) on Sale of Investments	-	4.23	-3.96	-2.89	31.7
Asset Writedown	-	-	-17.78	-24.89	-
Pretax Income	189.9	153.13	140.96	199.58	184.94
Income Tax Expense	26.86	25.02	25.25	18.12	-17.35
Earnings From Continuing Operations	163.04	128.1	115.71	181.45	202.29
Minority Interest in Earnings	-0.15	-0.11	0.07	0.33	-0.07
Net Income	162.89	128	115.78	181.79	202.22
Net Income to Common	162.89	128	115.78	181.79	202.22
Net Income Growth	27.26%	10.55%	-36.31%	-10.11%	113.33%
Shares Outstanding (Basic)	100	100	100	100	100
Shares Outstanding (Diluted)	101	100	100	101	106
Shares Change (YoY)	0.15%	0.08%	-0.34%	-4.70%	-6.53%
EPS (Basic)	1.63	1.28	1.16	1.82	2.03
EPS (Diluted)	1.62	1.27	1.15	1.81	1.93
EPS Growth	27.56%	10.44%	-36.46%	-6.16%	120.97%
Free Cash Flow	144.86	300.43	208.48	-9.97	153.28
Free Cash Flow Per Share	1.44	2.99	2.08	-0.10	1.45
Dividend Per Share	-	1.200	1.100	1.400	1.300
Dividend Growth	-	9.09%	-21.43%	7.69%	18.18%
Gross Margin	27.70%	28.15%	31.68%	25.70%	26.81%
Operating Margin	7.24%	6.94%	8.45%	7.87%	9.62%
Profit Margin	8.38%	6.91%	6.91%	8.10%	9.49%
Free Cash Flow Margin	7.45%	16.22%	12.44%	-0.44%	7.19%
EBITDA	201.65	182.03	206.52	260.08	291.6
EBITDA Margin	10.37%	9.83%	12.32%	11.59%	13.68%
D&A For EBITDA	60.93	53.56	64.8	83.52	86.65
EBIT	140.73	128.46	141.72	176.56	204.95
EBIT Margin	7.24%	6.94%	8.45%	7.87%	9.62%
Effective Tax Rate	14.14%	16.34%	17.91%	9.08%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.